Adage Capital Partners Gp, L.L.C. Deciphera Pharmaceuticals, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $393,898 - $473,389	29,661 New	29,661 $417,000
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $770,000 - $3.71 Million	-100,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $2.65 Million - $3.72 Million	100,000 New	100,000 $3.4 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $4.56 Million - $6.41 Million	-113,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $1.45 Million - $1.85 Million	-28,000 Reduced 19.86%	113,000 $6.45 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $6.18 Million - $8.2 Million	141,000 New	141,000 $7.23 Million
Q4 2017 Feb 14, 2018	SELL	$16.54 - $24.2 $4.14 Million - $6.05 Million	-250,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $4.41 Million - $4.75 Million	250,000	250,000 $4.75 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.